Search research articles
Contact Us
Filters
Showing results (281-290 of 355) with videos related to
Page
of 36
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2025
Bevacizumab, Atezolizumab, and Acetylsalicylic Acid in Recurrent, Platinum-Resistant Ovarian Cancer: The EORTC 1508-GCG Phase II Study
Susana Banerjee, Eleonora Ghisoni, Anita Wolfer, et al.
Cell Reports Methods
|
May 9, 2023
TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs
Raphael Genolet, Sara Bobisse, Johanna Chiffelle, et al.
Genes, Chromosomes & Cancer
|
May 13, 2011
Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcome
Jia Huang, Lin Zhang, Joel Greshock, et al.
Nature Biotechnology
|
March 5, 2020
Author Correction: A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapy
Greta Giordano-Attianese, Pablo Gainza, Elise Gray-Gaillard, et al.
Nature Biotechnology
|
February 5, 2020
A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapy
Greta Giordano-Attianese, Pablo Gainza, Elise Gray-Gaillard, et al.
EJNMMI Research
|
June 13, 2019
Internal radiation dosimetry of a <sup>152</sup>Tb-labeled antibody in tumor-bearing mice
Francesco Cicone, Silvano Gnesin, Thibaut Denoël, et al.
Nature Cancer
|
May 20, 2025
Age-associated nicotinamide adenine dinucleotide decline drives CAR-T cell failure
Helen Carrasco Hope, Jana de Sostoa, Pierpaolo Ginefra, et al.
Nature Cancer
|
May 1, 2023
The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer
Anne I Kraemer, Chloe Chong, Florian Huber, et al.
Journal for Immunotherapy of Cancer
|
January 21, 2025
Art of TIL immunotherapy: SITC's perspective on demystifying a complex treatment
Simon Turcotte, Marco Donia, Brian Gastman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2003
TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients
Katia Schlienger, Christina S Chu, Edward Y Woo, et al.
Page
of 36
Search research articles
Search
Showing results (281-290 of 355) with videos related to
Sort By:
Page
of 36
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2025
Bevacizumab, Atezolizumab, and Acetylsalicylic Acid in Recurrent, Platinum-Resistant Ovarian Cancer: The EORTC 1508-GCG Phase II Study
Susana Banerjee, Eleonora Ghisoni, Anita Wolfer, et al.
Cell Reports Methods
|
May 9, 2023
TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs
Raphael Genolet, Sara Bobisse, Johanna Chiffelle, et al.
Genes, Chromosomes & Cancer
|
May 13, 2011
Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcome
Jia Huang, Lin Zhang, Joel Greshock, et al.
Nature Biotechnology
|
March 5, 2020
Author Correction: A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapy
Greta Giordano-Attianese, Pablo Gainza, Elise Gray-Gaillard, et al.
Nature Biotechnology
|
February 5, 2020
A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapy
Greta Giordano-Attianese, Pablo Gainza, Elise Gray-Gaillard, et al.
EJNMMI Research
|
June 13, 2019
Internal radiation dosimetry of a <sup>152</sup>Tb-labeled antibody in tumor-bearing mice
Francesco Cicone, Silvano Gnesin, Thibaut Denoël, et al.
Nature Cancer
|
May 20, 2025
Age-associated nicotinamide adenine dinucleotide decline drives CAR-T cell failure
Helen Carrasco Hope, Jana de Sostoa, Pierpaolo Ginefra, et al.
Nature Cancer
|
May 1, 2023
The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer
Anne I Kraemer, Chloe Chong, Florian Huber, et al.
Journal for Immunotherapy of Cancer
|
January 21, 2025
Art of TIL immunotherapy: SITC's perspective on demystifying a complex treatment
Simon Turcotte, Marco Donia, Brian Gastman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2003
TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients
Katia Schlienger, Christina S Chu, Edward Y Woo, et al.
Page
of 36